Project Grant F31DA062410

Award Date 7/30/25
Completion Date Not listed
Dollars Obligated $49K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $789,677 to the Research Triangle Institute (RTI International) to conduct a community-based, longitudinal, mixed-methods study investigating the growing crisis of xylazine exposure among people who use drugs (PWUD) in the Southeastern U.S. The key products and services to be delivered through this funding include: 1) employing...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a $907,500 research study on the relationship between exposure to the drug xylazine and the risk of skin and soft tissue infections (SSTI) among people who inject drugs (PWID). The study will prospectively recruit 200 PWID in Lowell, Massachusetts and follow them for 3 months. It will quantify xylazine exposure using laboratory...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $233,250 to The Washington University in St. Louis to conduct research on the prevalence of the drug xylazine in the illicit drug supply and the etiology of xylazine-related invasive infections. The key objectives are to: 1) conduct active surveillance of the local illicit drug supply in St. Louis, Missouri using mass spectrometry and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $212,200 to the Research Triangle Institute (RTI International) to conduct a 24-month mixed-methods study examining the feasibility and acceptability of a community-based drug checking (CBDC) program operating through a syringe service program (SSP) in rural and tribal communities in Minnesota. The goal is to use the CBDC program to collect...
This $392,940 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the interactions between opioids and the veterinary drug xylazine. The research aims to improve understanding of why use of opioid/xylazine mixtures has rapidly increased, and to elucidate factors contributing to this trend, in order to drive the discovery of safe and effective treatments. The project, awarded...
This $387,750 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research by Mercer University to investigate the molecular pharmacology of the drug xylazine and its effects on adrenoceptors. The research aims to assess xylazine's binding affinity and functional profiles at different adrenoceptor subtypes expressed in vascular smooth muscle cells, as well as directly test the hypothesis that...
This $238,500 federal Project Grant award was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research to investigate the effects of the veterinary sedative xylazine, which has become prevalent in illicit opioid supplies, on inhibitory transmission in the prefrontal cortex. Specifically, the research aims to determine if xylazine and opioids exert synergistic effects on prefrontal cortex inhibitory...
This $146,922 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a mixed methods study to develop a natural language processing (NLP) algorithm to identify patients exposed to fentanyl adulterated with the veterinary sedative xylazine (FAAX). The research aims to advance understanding of FAAX-related overdose, skin wounds, withdrawal experiences, and treatment practices. The study will involve...
This Project Grant award, with an ID of R21DA061281, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $266,742 grant will fund a two-year qualitative study to characterize transitions to low-frequency injecting and injection cessation among people using xylazine-adulterated fentanyl in Connecticut. The study aims to (1) understand how exposure to xylazine-adulterated fentanyl intersects with social-structural...
This Project Grant award for $423,708 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support research to investigate the effects of fentanyl-xylazine drug mixtures on cardiorespiratory function and subjective effects in rats. Specifically, the research aims to characterize how xylazine impacts fentanyl-induced changes in heart rate, blood pressure, temperature, and respiration, as well as determine if...

UTILIZING MULTI-METHODS TO EXAMINE THE IMPACT OF XYLAZINE IN THE UNREGULATED DRUG SUPPLY - PROJECT SUMMARY / ABSTRACT THE OVERDOSE CRISIS IN THE UNITED STATES (US) HAS CONTRIBUTED SUBSTANTIALLY TO MORTALITY, DECREASED LIFE EXPECTANCY, AND INCREASED HEALTHCARE COSTS. XYLAZINE, A VETERINARY TRANQUILIZER NOT APPROVED FOR USE IN HUMANS, HAS EMERGED AS AN ADULTERANT TO THE UNREGULATED OPIOID SUPPLY. THIS HAS CREATED A RISING CONCERN AMONGST PUBLIC HEALTH PRACTITIONERS, HEALTHCARE PROVIDERS, AND HARM REDUCTIONISTS ALIKE, AS THERE IS EVIDENCE THAT XYLAZINE (A) MAY BE CONTRIBUTING TO THE RISE IN OPIOID OVERDOSES THROUGH INCREASED RESPIRATORY DEPRESSION AND DECREASED HEART RATE AND (B) CAN INDUCE PAINFUL SKIN ULCERS THAT CAN HAVE EXTENSIVE NECROSIS AND ARE VULNERABLE TO INFECTION. HOWEVER, DUE TO THE NOVELTY OF THIS ADULTERANT IN THE US, PEOPLE WHO USE DRUGS (PWUD) AND THOSE THAT PROVIDE SERVICES TO PWUD HAVE VERY LITTLE INFORMATION ABOUT THIS SUBSTANCE AND ITS RELATED SEQUELAE. THUS, IN THIS PROPOSAL I WILL PURSUE TWO MULTI-METHODS STUDIES TO CHARACTERIZE THE IMPACT OF XYLAZINE ON PWUD. THE FIRST STUDY, BASED IN NORTH CAROLINA, AIMS TO DESCRIBE THE PERCEPTIONS OF AND EXPERIENCES WITH XYLAZINE AND ITS RELATED COMPLICATIONS (I.E., WOUNDS AND OVERDOSES) AMONG PWUD. I WILL COLLABORATE WITH NORTH CAROLINA SURVIVORS UNION TO RECRUIT PARTICIPANTS AND USE BOTH SURVEY AND INTERVIEW METHODOLOGIES TO ASCERTAIN HOW XYLAZINE IS IMPACTING PWUD'S DRUG USE BEHAVIOR, HEALTH OUTCOMES, AND HEALTHCARE SEEKING/ACCESS. MY SECOND STUDY IS BASED IN MAINE AND AIMS TO BOTH (A) ELUCIDATE THE FEASIBILITY AND ACCEPTABILITY OF A COMMUNITY-BASED DRUG CHECKING PROGRAM THAT ALLOWS PWUD TO TEST THEIR DRUGS FOR XYLAZINE AND (B) QUALITATIVELY AND QUANTITATIVELY DESCRIBE DRUG SUPPLY CHANGES OVER TIME. TO ASSESS FEASIBILITY AND ACCEPTABILITY OF A DRUG CHECKING INTERVENTION, WE WILL CONDUCT FOCUS GROUPS AMONGST PWUD, STAFF OF SYRINGE SERVICE PROGRAMS IMPLEMENTING DRUG CHECKING, AND MEDICAL CARE PROVIDERS. TO DESCRIBE DRUG SUPPLY CHANGES OVER TIME, WE WILL ANALYZE CHEMICAL ANALYSIS SAMPLES OF DRUGS PROVIDED TO THREE SYRINGE SERVICE PROGRAMS IN MAINE. DRUG CHECKING, FROM BOTH FOURIER-TRANSFORM INFRARED (FTIR) SPECTROSCOPY TESTS IN THE FIELD AND CONFIRMATORY GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS) CONDUCTED IN AN ACADEMIC LABORATORY, WILL HELP IMPROVE EPIDEMIOLOGICAL SURVEILLANCE OF THE VOLATILE DRUG SUPPLY IN MAINE. THROUGH RIGOROUS SCIENTIFIC EVIDENCE, OUR STUDY IS DESIGNED TO IDENTIFY KEY STRATEGIES FOR REDUCING THE HARMS ASSOCIATED WITH XYLAZINE AMONG PWUD. THIS MULTI-METHODS PROPOSAL ULTIMATELY HOPES TO INFORM BOTH MEDICAL CARE AND HARM REDUCTION BEST PRACTICES.

Posted 1/30/25, 12:00 AM